A Study of Tazemetostat in Combination With HMPL-689 in Patients With Relapsed/Refractory Lymphoma

Clinical trial NCT05713110 · COMPLETED

Trial details

NCT number: NCT05713110
Sponsor: Hutchmed
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed/Refractory Lymphoma

Start date: 2023-02-13
Primary completion: 2024-12-31
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.